Silvia Pérez

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 479 citations

Rheumatoid Disorder, Rheumatology, Tofacitinib Monotherapy +8

The 2-series prostaglandins suppress VLDL secretion in an inflammatory condition-dependent manner in primary rat hepatocytes

Silvia Pérez, Patricia Aspichueta, Begoña Ochoa et al. · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 2006 · 42 citations

Inflammation, Cytokine, Anti-inflammatory +13

Influence of MHCIITA rs3087456 and rs4774 polymorphisms in the susceptibility to cardiovascular disease of patients with rheumatoid arthritis.

Mercedes García-Bermúdez, C González-Juanatey, Raquel López‐Mejías et al. · PubMed · 2012 · 28 citations

Lack of association between IL6 single nucleotide polymorphisms and cardiovascular disease in Spanish patients with rheumatoid arthritis

Raquel López‐Mejías, Mercedes García-Bermúdez, Carlos González‐Juanatey et al. · Atherosclerosis · 2011 · 21 citations

Rheumatoid Disorder, Rheumatology, Epidemiology +12

Effects of disease activity on lipoprotein levels in patients with early arthritis: can oxidized LDL cholesterol explain the lipid paradox theory?

Ana M. Fernández-Ortiz, Ana M. Ortiz, Silvia Pérez et al. · Arthritis Research & Therapy · 2020 · 20 citations · Full text